Our portfolio company Risklick, a Swiss-based company specializing in AI-driven solutions for clinical trial protocol development, has announced a strategic partnership with Citeline, a leader in clinical solutions for the life sciences industry, to launch an integrated solution for digital protocol design and optimization. By combining Citeline’s robust R&D intelligence with Risklick’s Protocol AI™ platform, the collaboration enables sponsors to transition from manual workflows to a high-speed, AI-driven engine. This data-driven approach reduces the risk of costly protocol amendments and accelerates clinical timelines, helping to bring new therapies to patients more efficiently.
